Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients

Clinical trial NCT03924466 · UNKNOWN

Trial details

NCT number: NCT03924466
Sponsor: Universitair Ziekenhuis Brussel
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Carcinoma Locally Advanced Breast Cancer Cancer of Pancreas Solid Tumor With Intermediate or High HER2 Expression Salivary Gland Cancer Gastric Cancer Endometrial Cancer Uterine Cancer Non Small Cell Lung Cancer Biliary Tract Cancer Cholangiocarcinoma Colorectal Cancer

Start date: 2019-04-01
Primary completion: 2024-11-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.